Cooper Companies beats quarterly estimates on strong contact lenses demand (updated)
UPDATE 2-Cooper Companies beats quarterly estimates on strong contact lenses demand Adds shares in paragraphs 2, company comments throughout
By Kunal Das
June 4 (Reuters) - Cooper Companies COO.O beat Wall Street estimates for second-quarter profit and revenue on Thursday, helped by sustained demand for its contact lenses.
Shares of the San Ramon, California-based company were up about 5% in extended trading following the results.
Contact lens makers, including Cooper and Bausch + Lomb BLCO.TO, are expected to benefit this year from the shift to premium daily disposable lenses and growing global demand for vision correction.
However, Cooper lowered its annual revenue forecast, while keeping its profit outlook unchanged.
It expects fiscal 2026 revenue of $4.29 billion to $4.32 billion, compared with its prior forecast of $4.31 billion to $4.35 billion. The company maintained its annual adjusted profit per share forecast of $4.58 to $4.66.
Analysts on average expect 2026 revenue of $4.32 billion and profit of $4.62 per share, according to data compiled by LSEG.
The company's forecast was "prudent," reflecting higher costs and a lower revenue outlook for CooperVision, CFO Brian Andrews said.
For the second quarter, revenue came at $1.08 billion, above analysts' average estimate of $1.05 billion.
Cooper Vision, its contact lens business, posted second-quarter revenue of $723.5 million, topping estimates of $710.2 million.
The segment's Asia-Pacific revenue fell 6% to $130.6 million from a year ago. Analysts have previously flagged that Asia-Pacific remains an area of focus for contact lens makers after pockets of weakness in the region weighed on the market.
Cooper expects contact lens market growth at the low end of its historical 4% to 6% range, with Asia-Pacific weighing on the category while the Americas and EMEA remain healthy, CEO Albert White said.
CooperVision's Asia-Pacific business is expected to decline in the third quarter, pressured by the broader market and the company's rationalization of legacy hydrogel products, he added.
Cooper's quarterly adjusted profit of $1.21 per share surpassed estimates of $1.10.
(Reporting by Kunal Das in Bengaluru; Editing by Shreya Biswas)
Recent news on Bausch + Lomb
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: US FDA sent warning letter to Bausch & Lomb on September 4
Brief: Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser